Literature DB >> 10976756

Membrane permeability of fructose-1,6-diphosphate in lipid vesicles and endothelial cells.

W D Ehringer1, W Niu, B Chiang, O L Wang, L Gordon, S Chien.   

Abstract

Fructose-1,6-diphosphate (FDP) is a glycolytic intermediate which has been used an intervention in various ischemic conditions for two decades. Yet whether FDP can enter the cell is under constant debate. In this study we examined membrane permeability of FDP in artificial membrane bilayers and in endothelial cells. To examine passive diffusion of FDP through the membrane bilayer, L-alpha-phosphatidylcholine from egg yolk (Egg PC) (10 mM) multi-lamellar vesicles were created containing different external concentrations of FDP (0, 0.5, 5 and 50 mM). The passive diffusion of FDP into the vesicles was followed spectrophotometrically. The results indicate that FDP diffuses through the membrane bilayer in a dose-dependent fashion. The movement of FDP through Egg PC membrane bilayers was confirmed by measuring the conversion of FDP to dihydroxyacetone-phosphate and the formation of hydrozone. FDP (0, 0.5, 5 or 50 mM) was encapsulated in Egg PC multilamellar vesicles and placed in a solution containing aldolase. In the 5 and 50 mM FDP groups there was a significant increase in dihydroxyacetone/hydrazone indicating that FDP crossed the membrane bilayer intact. We theorized that the passive diffusion of FDP might be due to disruption of the membrane bilayer. To examine this hypothesis, small unilamellar vesicles composed of Egg PC were created in the presence of 60 mM carboxyfluorescein, and the leakage of the sequestered dye was followed upon addition of various concentrations of FDP, fructose, fructose-6-phosphate, or fructose-1-phosphate (0, 5 or 50 mM). These results indicate that increasing concentrations of FDP increase the leakage rate of carboxyfluorescein. In contrast, no concentration of fructose, fructose-6-phosphate, or fructose-1-phosphate resulted in any significant increase in membrane permeability to carboxyfluorescein. To examine whether FDP could pass through cellular membranes, we examined the uptake of 14C-FDP by endothelial cells cultured under hypoxia or normoxia for 4 or 16 h. The uptake of FDP was dose-dependent in both the normoxia and hypoxia treated cells, and was accompanied by no significant loss in endothelial cell viability. Our results demonstrate that FDP can diffuse through membrane bilayers in a dose-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10976756     DOI: 10.1023/a:1007059214754

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

1.  Comparison of protection by fructose against paracetamol injury with protection by glucose and fructose-1,6-diphosphate.

Authors:  F L Martin; A E McLean
Journal:  Toxicology       Date:  1996-04-30       Impact factor: 4.221

2.  Lipid composition and permeability of liposomes.

Authors:  J de Gier; J G Mandersloot; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1968-06-11

3.  Hepatic preservation with a cold-storage solution containing fructose-1,6-diphosphate and mannitol: evaluation with the isolated perfused rat liver and comparison with University of Wisconsin solution.

Authors:  J Torras; F G Borobia; I Herrero; M Carrera; M Riera; R Bartrons; J Figueras; J Alsina; J M Cruzado; E Jaurrieta
Journal:  Transplant Proc       Date:  1995-08       Impact factor: 1.066

4.  Reversible effects of chaotropic agents on the proton permeability of Escherichia coli membrane vesicles.

Authors:  L Patel; S Schuldiner; H R Kaback
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

Review 5.  Metabolic intervention to affect myocardial recovery following ischemia.

Authors:  M K Pasque; A S Wechsler
Journal:  Ann Surg       Date:  1984-07       Impact factor: 12.969

6.  Requirement of glycolytic substrate for metabolic recovery during moderate low flow ischemia.

Authors:  S Schaefer; E Prussel; L J Carr
Journal:  J Mol Cell Cardiol       Date:  1995-10       Impact factor: 5.000

7.  Effect of exogenous fructose-1,6-bisphosphate on glycolysis in the isolated perfused rat heart.

Authors:  E M Nuutinen; G Lazzarino; B Giardina; I E Hassinen
Journal:  Am Heart J       Date:  1991-08       Impact factor: 4.749

8.  Metabolism of exogenously applied fructose 1,6-bisphosphate in hypoxic vascular smooth muscle.

Authors:  C D Hardin; T M Roberts
Journal:  Am J Physiol       Date:  1994-12

9.  Transient permeabilization induced osmotically in membrane vesicles from Torpedo electroplax: a mild procedure for trapping small molecules.

Authors:  L K West; L Huang
Journal:  Biochemistry       Date:  1980-09-16       Impact factor: 3.162

10.  Mechanism of the effect of exogenous fructose 1,6-bisphosphate on myocardial energy metabolism.

Authors:  I E Hassinen; E M Nuutinen; K Ito; S Nioka; G Lazzarino; B Giardina; B Chance
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

View more
  12 in total

1.  Direct energy delivery improves tissue perfusion after resuscitated shock.

Authors:  El Rasheid Zakaria; William D Ehringer; Nina Tsakadze; Na Li; R Neal Garrison
Journal:  Surgery       Date:  2005-08       Impact factor: 3.982

2.  Characterization of the high-affinity uptake of fructose-1,6-bisphosphate by cardiac myocytes.

Authors:  Thomas J Wheeler; Sufan Chien
Journal:  Mol Cell Biochem       Date:  2012-03-18       Impact factor: 3.396

3.  Inhibition of fatty acid synthase with C75 decreases organ injury after hemorrhagic shock.

Authors:  Michael Kuncewitch; Weng Lang Yang; Asha Jacob; Adam Khader; Matthew Giangola; Jeff Nicastro; Gene F Coppa; Ping Wang
Journal:  Surgery       Date:  2015-09-12       Impact factor: 3.982

4.  The uptake and metabolism of fructose-1,6-diphosphate in rat cardiomyocytes.

Authors:  W D Ehringer; B Chiang; S Chien
Journal:  Mol Cell Biochem       Date:  2001-05       Impact factor: 3.396

5.  Destabilizing effects of fructose-1,6-bisphosphate on membrane bilayers.

Authors:  William D Ehringer; Susan Su; Benjamin Chiangb; William Stillwell; Sufan Chien
Journal:  Lipids       Date:  2002-09       Impact factor: 1.880

6.  Fructose-1,6-bisphosphate reduces inflammatory pain-like behaviour in mice: role of adenosine acting on A1 receptors.

Authors:  D A Valério; F I Ferreira; T M Cunha; J C Alves-Filho; F O Lima; J R De Oliveira; S H Ferreira; F Q Cunha; R H Queiroz; W A Verri
Journal:  Br J Pharmacol       Date:  2009-07-23       Impact factor: 8.739

7.  Fructose-1,6-diphosphate attenuates prostaglandin E2 production and cyclo-oxygenase-2 expression in UVB-irradiated HaCaT keratinocytes.

Authors:  Soo Mi Ahn; Hyoung-Young Yoon; Byung Gon Lee; Kyoung Chan Park; Jin Ho Chung; Chang-Hyun Moon; Soo Hwan Lee
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

8.  Permeability of fructose-1,6-bisphosphate in liposomes and cardiac myocytes.

Authors:  Thomas J Wheeler; John M McCurdy; Aaron denDekker; Sufan Chien
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

9.  Pharmacokinetics of fructose-1,6-diphosphate after intraperitoneal and oral administration to adult rats.

Authors:  Kaiping Xu; Janet L Stringer
Journal:  Pharmacol Res       Date:  2008-02-02       Impact factor: 7.658

10.  Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials.

Authors:  Jørn Ditzel; Hans Henrik Lervang
Journal:  Diabetes Metab Syndr Obes       Date:  2009-10-08       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.